Although the addition of DAPA to the VA group (the DAPA+VA group) resulted in a decreasing trend in MDA levels compared to the VA group, this difference was not statistically significant ( Figure 2 A).
← all excerpts
The Effect of Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats.
2
—
—
The sentences
In the DAPA+VA group, these scores were lower than those in the VA group; although the differences did not reach statistical significance, DAPA treatment was associated with a trend toward reduction in the VA-induced increases in TNF-α (the most pronounced trend), IL-1β, and IL-6.